Citigroup’s CalciMedica CALC Stock Holding History

Citigroup’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-985	Closed	-$15.2K	–	6102
2025 Q3	$15.2K	Buy	+985	New	+$14.2K	﹤0.01%	4902
2022 Q2	–	Hold	0	–	–	–	6261
2022 Q1	–	Hold	0	–	–	–	6324
2021 Q2	–	Sell	-6	Closed	-$2K	–	6140
2021 Q1	$2K	Sell	6 -11	-65%	-$16.5K	﹤0.01%	6040
2020 Q4	$35K	Buy	+17	New	+$25.1K	﹤0.01%	6280

Other funds holding CALC

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MPM

Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return

Citigroup's CALC Position: Q4 2025 in Review

Citigroup sold out of CalciMedica (CALC) in Q4 2025, closing a stake of 985 shares — an estimated $15.2K sold.

Citigroup first reported a position in CALC in Q4 2020 and held it in 3 quarters. The position peaked at $35K in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q4 2025.

Citigroup reported no remaining CalciMedica position as of Q4 2025 after selling out during the quarter.
Citigroup sold 985 CalciMedica shares in Q4 2025, an estimated $15.2K.
Citigroup first reported a position in CalciMedica in Q4 2020 and held it in 3 quarters.
Citigroup's CalciMedica position peaked at $35K in Q4 2020.
31 funds tracked by Wall St. Rank held CalciMedica as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.